# Samphire Neuroscience

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/samphire-neuroscience

- Industry: Medical Devices & Equipment
- Headquarters: London, UK
- Website: www.samphireneuro.com
- Total disclosed funding: $5M
- Latest round: Seed (Jun 2, 2025)
- Investors on record: 8

## About

Based in London, UK, and founded in 2021, Samphire Neuroscience Ltd. operates as a developer and provider of wearable neurotechnology products, intended to address various menstrual-cycle related challenges faced by women. In June 2025, Samphire Neuroscience Ltd. raised USD 5 million in series A funding led by new investor Inventure, with participation from another new investor Fortify Ventures. The company focuses on the development of proprietary wearable neurotechnology products, that are designed to help women from their menstrual-cycle-related health problems. The firm’s first product is a device that can be worn as a headband by women, and it utilizes non-invasive electrical neuromodulation technology to stimulate the brain, thereby reducing or minimizing the general symptoms of menstruation including body pain, mood variability, fuzziness, stress, and fatigue. The company will use the June 2025 funding for development and expand its market reach.

## Funding rounds

- Seed, Jun 2, 2025, $5M — Inventure, SOSV, Fortify Ventures, Afterwork Ventures, Seaside Ventures, APEX Capital, FIRSTPICK, Ayuh Ventures
- Seed, Dec 17, 2021 — SOSV

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed
- Inventure (https://capitalatlas.ai/funds/inventure) — Seed
- Fortify Ventures (https://capitalatlas.ai/funds/fortify-ventures) — Seed
- Afterwork Ventures (https://capitalatlas.ai/funds/afterwork-ventures) — Seed
- Seaside Ventures (https://capitalatlas.ai/funds/seaside-ventures) — Seed
- APEX Capital — Seed
- FIRSTPICK (https://capitalatlas.ai/funds/firstpick) — Seed
- Ayuh Ventures — Seed